Skip to Main Content

SAN FRANCISCO — Running mouse experiments has long been one of the most unglamorous parts of developing drugs.

But Vium, a startup out of Silicon Valley with high-profile venture backing, wants the industry to think differently.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!